YSXT vs NAMI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

YSXT

46.2
AI Score
VS
NAMI Wins

NAMI

47.3
AI Score

Investment Advisor Scores

YSXT

46score
Recommendation
HOLD

NAMI

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric YSXT NAMI Winner
Revenue 83.47M 59.06M YSXT
Net Income 2.80M -13.49M YSXT
Gross Margin 8.6% 11.0% NAMI
Net Margin 3.4% -22.8% YSXT
Operating Income 3.54M -14.91M YSXT
ROE 8.3% -112.5% YSXT
ROA 5.1% -49.1% YSXT
Total Assets 54.96M 27.49M YSXT
Cash 5.89M 9.19M NAMI
Current Ratio 2.79 1.53 YSXT
Free Cash Flow -2.77M -3.63M YSXT

Relative Price Performance (Last 90 Days)

YSXT 1M: -24.1% · 3M: -3.1% NAMI 1M: -20.2% · 3M: +596.6%

Current Technical Phase

YSXT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.2 · Price: $0.91

NAMI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (147.8% over 20 days), RSI 52

RSI (14): 51.6 · Price: $2.76

Fundamentals Snapshot

Metric YSXT NAMI
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 8.5
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% -0.4%
EPS 0.11 -4.66
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NAMI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.